Our previous studies demonstrated that the EMT transcription factor Zeb1 is required for maintaining epithelial versus mesenchymal balance in vivo in the mouse,
13 and overexpression of Zeb1 and the other EMT transcription factors in cancer drive EMT and a metastatic phenotype in cancer cells.
14–16 Furthermore, induction of the EMT transcription factors can initiate reprogramming of differentiated somatic cells to cells with properties of cancer stem cells,
17,18 and we have recently found that overexpression of Zeb1 has an important role in cancer stem cell generation.
17 Additionally, we found recently that Zeb1 is overexpressed as retinal pigment epithelial cells initiate proliferation and undergo EMT dedifferentiation when placed in primary culture.
19 Zeb1 is a transcriptional repressor,
20 and we demonstrated that one of its targets is
Mitf, which is required for RPE specification.
19,21,22 Even heterozygous mutation of Zeb1 is sufficient to prevent loss of Mitf expression, onset of proliferation, and initiation of EMT in the cultured RPE cells. A similar result was seen with shRNA knockdown of Zeb1. In these studies we found that Zeb1 expression in the RPE was dependent on cell-cell contact, and only cells in culture that lost such cell-cell contact induced Zeb1, initiated proliferation, and underwent EMT. Furthermore, when dedifferentiated proliferating RPE cells expressing a high level of Zeb1 were forced to reform cell-cell only contacts, Zeb1 expression was silenced.
19 This loss of Zeb1 in turn led to reexpression of Mitf, restoration of epithelial morphology and pigment synthesis, and loss of proliferation. These results suggested that induction of Zeb1, as a result of loss of cell-cell contact, is important for the dedifferentiating EMT that occurs in RPE cells in culture and that this dedifferentiation can be reversed if Zeb1 expression is downregulated.